Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Blood Cancer Discovery|September 27, 2021
Scalable Manufacturing of CAR T cells for Cancer ImmunotherapyMohamed Abou-El-Enein, Magdi Elsallab, Steven A Feldman, et al.
Blood|May 6, 2015
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugsSoranobu Ninomiya, Neeharika Narala, Leslie Huye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 2, 2011
CARs on track in the clinicDonald B Kohn, Gianpietro Dotti, Renier Brentjens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2013
T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivoClaudia Geldres, Barbara Savoldo, Valentina Hoyos, et al.
Oncotarget|May 2, 2019
Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myelomaChuang Sun, Aruna Mahendravada, Brandon Ballard, et al.
Blood Advances|December 1, 2020
Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapyTimothy J Voorhees, Nilanjan Ghosh, Natalie Grover, et al.
Clinical Transplantation|July 11, 2006
Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipientsTimothy C Lee, Barbara Savoldo, Neal R Barshes, et al.
Science Translational Medicine|March 2, 2018
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapySerena Pellegatta, Barbara Savoldo, Natalia Di Ianni, et al.
Blood|August 24, 2006
T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cellsJuan Vera, Barbara Savoldo, Stephane Vigouroux, et al.
Blood|May 18, 2007
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin diseaseBarbara Savoldo, Cliona M Rooney, Antonio Di Stasi, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Blood Cancer Discovery|September 27, 2021
Scalable Manufacturing of CAR T cells for Cancer ImmunotherapyMohamed Abou-El-Enein, Magdi Elsallab, Steven A Feldman, et al.
Blood|May 6, 2015
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugsSoranobu Ninomiya, Neeharika Narala, Leslie Huye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 2, 2011
CARs on track in the clinicDonald B Kohn, Gianpietro Dotti, Renier Brentjens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2013
T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivoClaudia Geldres, Barbara Savoldo, Valentina Hoyos, et al.
Oncotarget|May 2, 2019
Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myelomaChuang Sun, Aruna Mahendravada, Brandon Ballard, et al.
Blood Advances|December 1, 2020
Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapyTimothy J Voorhees, Nilanjan Ghosh, Natalie Grover, et al.
Clinical Transplantation|July 11, 2006
Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipientsTimothy C Lee, Barbara Savoldo, Neal R Barshes, et al.
Science Translational Medicine|March 2, 2018
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapySerena Pellegatta, Barbara Savoldo, Natalia Di Ianni, et al.
Blood|August 24, 2006
T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cellsJuan Vera, Barbara Savoldo, Stephane Vigouroux, et al.
Blood|May 18, 2007
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin diseaseBarbara Savoldo, Cliona M Rooney, Antonio Di Stasi, et al.
Pageof 16